| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 4,139,212 | 3,148,203 |
| Net increase (decrease) in cash | 952,089 | 1,394,060 |
| Cash and cash equivalents at beginning of period | 157,139 | - |
| Cash and cash equivalents at end of period | 1,109,228 | - |
Longevity Health Holdings, Inc. (XAGEW)
Longevity Health Holdings, Inc. (XAGEW)